• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diabetes Technology Innovations Special Report — 2026

August 5, 2026 By Sean Whooley

MD-DDBN-Diabetes-Special-Report26-COVER-1-scaledLast year, MassDevice and Drug Delivery Business News rolled out the first edition of their Diabetes Technology Innovations Special Report.

Now, we have the second edition available for free download, providing an in-depth overview of where the diabetes industry currently stands after another year of innovation and growth.

The diabetes tech industry delivers some of the most advanced combinations of medtech and consumer devices. Various companies around the world — including major companies such as Abbott, Dexcom, MiniMed, Insulet, and Roche — are giving people with diabetes numerous options when it comes to the type of technology they want to use. Personalization, miniaturization, and more are at the forefront of innovation in the diabetes space, and the past year has seen significant efforts to further enhance these life-saving technologies.

In this report, you will find the biggest diabetes tech stories of the year, including significant strategy shifts, next-gen continuous glucose monitoring (CGM) and automated insulin delivery systems, and more. It also features exclusive interviews with executives from some of the industry leaders — plus a list of the world’s 10 largest diabetes technology companies and some of the other noteworthy companies advancing diabetes tech.

This special report covers it all as we continue to watch the diabetes technology space innovate..

Download our Diabetes Technology Special Report to learn more!

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Beta Bionics, Dexcom, embecta, Insulet, minimed, MyLife Diabetes Care, Roche, Roche Diabetes Care, Senseonics, Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board
  • MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS